Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Janssen Pharmaceuticals, Inc.
Current Parent Company: Johnson & Johnson
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Penalty: $410,000,000
Year: 2013
Date: January 3, 2013
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Mega-Scandal: Pharmaceutical Hazards
Violation Description: Janssen Pharmaceuticals pleaded guilty to a charge of introducing a misbranded drug, Risperdal, into interstate commerce and was ordered to pay a $344 million fine and forfeiture of $66 million.
Level of Government: federal
Action Type: agency action
Agency: U.S. Attorney-Eastern District of Pennsylvania
Civil or Criminal Case: criminal
HQ Country of Current Parent: USA
HQ State of Current Parent: New Jersey
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.